TEL-AML1 Transgenic Zebrafish Model of Precursor B Cell Acute Lymphoblastic Leukemia
Overview
Authors
Affiliations
Acute lymphoblastic leukemia (ALL) is a clonal disease that evolves through the accrual of genetic rearrangements and/or mutations within the dominant clone. The TEL-AML1 (ETV6-RUNX1) fusion in precursor-B (pre-B) ALL is the most common genetic rearrangement in childhood cancer; however, the cellular origin and the molecular pathogenesis of TEL-AML1-induced leukemia have not been identified. To study the origin of TEL-AML1-induced ALL, we generated transgenic zebrafish expressing TEL-AML1 either ubiquitously or in lymphoid progenitors. TEL-AML1 expression in all lineages, but not lymphoid-restricted expression, led to progenitor cell expansion that evolved into oligoclonal B-lineage ALL in 3% of the transgenic zebrafish. This leukemia was transplantable to conditioned wild-type recipients. We demonstrate that TEL-AML1 induces a B cell differentiation arrest, and that leukemia development is associated with loss of TEL expression and elevated Bcl2/Bax ratio. The TEL-AML1 transgenic zebrafish models human pre-B ALL, identifies the molecular pathways associated with leukemia development, and serves as the foundation for subsequent genetic screens to identify modifiers and leukemia therapeutic targets.
Mutalik C, Nivedita , Sneka C, Krisnawati D, Yougbare S, Hsu C Int J Mol Sci. 2024; 25(3).
PMID: 38339204 PMC: 10856345. DOI: 10.3390/ijms25031926.
Eldeeb M, Konturek-Ciesla A, Zhang Q, Kharazi S, Tingvall-Gustafsson J, Ungerback J Leukemia. 2024; 38(2):455-459.
PMID: 38243088 PMC: 10844086. DOI: 10.1038/s41375-024-02149-2.
Learning from Zebrafish Hematopoiesis.
Wu M, Xu J, Zhang Y, Wen Z Adv Exp Med Biol. 2024; 1442:137-157.
PMID: 38228963 DOI: 10.1007/978-981-99-7471-9_9.
Zapilko V, Moisio S, Parikka M, Heinaniemi M, Lohi O Cancers (Basel). 2023; 15(24).
PMID: 38136366 PMC: 10871125. DOI: 10.3390/cancers15245821.
Rothschild S, Lai G, Tombes R, Clements W PLoS Genet. 2023; 19(12):e1011102.
PMID: 38117861 PMC: 10766190. DOI: 10.1371/journal.pgen.1011102.